Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion
2023
Exosome-based Drug Delivery for Diabetes Treatment
publication
Evidence: moderate
Author Information
Author(s): Chen Qi, Chen Jie, Liu Yi-Ning, Qi Su-Hua, Huang Lin-Yan
Primary Institution: Xuzhou Medical University
Hypothesis
Exosome-based therapy can improve drug delivery for diabetes and its complications.
Conclusion
Exosomes show great potential as drug carriers for treating diabetes and its complications.
Supporting Evidence
- Exosomes can protect insulin from degradation and improve its bioavailability.
- Engineered exosomes can enhance the effectiveness of diabetes medications.
- Exosomes can improve wound healing in diabetic patients.
- Exosomes can deliver miRNAs that promote insulin sensitivity.
Takeaway
Exosomes are tiny bubbles that can carry medicine to help treat diabetes and its problems, making them a promising new way to deliver drugs.
Methodology
This review summarizes the benefits of exosomal drug delivery systems, drug loading methods, and their applications in treating diabetes.
Limitations
Challenges include large-scale production, assessing exosome contents, and monitoring treatment safety and effectiveness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website